Apollo Hospitals Enterprise Limited

NSE: APOLLOHOSP

23

total announcements

APOLLOHOSP.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 14 Oct 2026

Market Cap

₹1.13 L Cr

P/E (TTM)

52.5

P/E (Forward)

36.1

EPS (TTM)

₹149.98

52W Low

₹6,696.50

52W High

₹9,070.50

Dividend Yield

0.26%

Beta

0.17

Price / Book

11.9

Debt / Equity

85.1

Revenue (TTM)

₹26,430 Cr

Gross Margin

35.21%

Operating Margin

12.17%

NSEScheme of ArrangementM&A24 Jun 2026

Apollo Hospitals Enterprise Limited

Scheme of Arrangement

Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement proceedings, including meetings of secured creditors, unsecured creditors, and equity shareholders, held on June 24, 2026, to consider and approve the composite scheme of arrangement amongst Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.

Read more →📎 1 attachment
NSEShareholders meetingRegulatory24 Jun 2026

Apollo Hospitals Enterprise Limited

Shareholders meeting

Apollo Hospitals Enterprise Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on Jun 24, 2026, along with a copy of minutes. The meeting was held to consider and approve the composite scheme of arrangement amongst Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited, and their respective shareholders and creditors, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.

Read more →📎 1 attachment
NSEScheme of Arrangement19 Jun 2026

Apollo Hospitals Enterprise Limited

Scheme of Arrangement

Apollo Hospitals Enterprise Limited has announced a proposed composite scheme of arrangement involving itself and three other entities: Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. This restructuring initiative falls under Sections 230 to 232 of the Companies Act, 2013. While the initial announcement does not disclose specific financial figures or the full details of the scheme, it signals a significant corporate restructuring. Investors should monitor for further disclosures, as such arrangements can impact the company's business segments, asset allocation, and future valuations.

Read more →📎 1 attachment
← PreviousPage 2 of 2